XML 34 R6.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated Statements of Stockholders' Equity - USD ($)
Total
Preferred Stock
Common Stock
Capital in Excess of Par
Accumulated Other Comprehensive Loss
(Accumulated Deficit) Retained Earnings
Treasury Stock
Preferred stock, Beginning balance (in shares) at Dec. 31, 2023   0          
Common stock, Beginning balance (in shares) at Dec. 31, 2023     12,248,313        
Stockholders' equity beginning of period at Dec. 31, 2023 $ 34,504,139 $ 0 $ 122,483 $ 75,338,010 $ (12,274,563) $ (23,114,310) $ (5,567,481)
Treasury stock, Beginning balance (in shares) at Dec. 31, 2023             1,471,406
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation 1,382,912     1,382,912      
Vesting of restricted stock awards (in shares)     518,405        
Vesting of restricted stock awards 0   $ 5,184 (5,184)      
Shares deducted from restricted stock awards for payment of withholding taxes (in shares)     (132,210)        
Shares deducted from restricted stock awards for payment of withholding taxes (1,310,641)   $ (1,321) (1,309,320)      
Exercise of stock options (in shares)     71,997       52,719
Exercise of stock options 63,711   $ 721 63,516     $ (526)
Issuance of common stock (in shares)     1,437,287        
Issuance of common stock 13,610,807   $ 14,370 13,596,437      
Exercise of warrants (in shares)     304,413        
Exercise of warrants 0   $ 3,045 (3,045)      
Net income 18,358,436         18,358,436  
Decrease in unrealized losses on available- for-sale securities, net of tax $ 99,087       99,087    
Preferred stock, Ending balance (in shares) at Dec. 31, 2024   0          
Common stock, Ending balance (in shares) at Dec. 31, 2024 12,924,080   14,448,205        
Stockholders' equity end of period at Dec. 31, 2024 $ 66,708,451 $ 0 $ 144,482 89,063,326 (12,175,476) (4,755,874) $ (5,568,007)
Treasury stock, Ending balance (in shares) at Dec. 31, 2024 1,524,125           1,524,125
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation $ 1,482,357     1,482,357      
Vesting of restricted stock awards (in shares)     231,613        
Vesting of restricted stock awards 0   $ 2,316 (2,316)      
Shares deducted from restricted stock awards for payment of withholding taxes (in shares)     (36,902)        
Shares deducted from restricted stock awards for payment of withholding taxes $ (562,214)   $ (369) (561,845)      
Exercise of stock options (in shares) 27,923   51,487        
Exercise of stock options $ 62,714   $ 515 62,199      
Shares deducted from exercise of stock options for payment of withholding taxes     (868)        
Shares deducted from exercise of stock options for payment of withholding taxes (14,305)   $ (9) (14,296)      
Issuance of common stock - employee stock purchase plan (in shares)     10,729        
Issuance of common stock - employee stock purchase plan 137,116   $ 107 137,009      
Issuance of common stock (in shares)     612,999        
Issuance of common stock 9,470,453   $ 6,130 9,464,323      
Exercise of warrants (in shares)     604,388        
Exercise of warrants 0   $ 6,044 (6,044)      
Dividends (1,414,397)         (1,414,397)  
Net income 40,767,128         40,767,128  
Decrease in unrealized losses on available- for-sale securities, net of tax $ 6,093,946       6,093,946    
Preferred stock, Ending balance (in shares) at Dec. 31, 2025   0          
Common stock, Ending balance (in shares) at Dec. 31, 2025 14,397,526   15,921,651        
Stockholders' equity end of period at Dec. 31, 2025 $ 122,731,249 $ 0 $ 159,216 $ 99,624,713 $ (6,081,530) $ 34,596,857 $ (5,568,007)
Treasury stock, Ending balance (in shares) at Dec. 31, 2025 1,524,125           1,524,125